Global Castrate Resistant Prostate Cancer Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Prostate Cancer
The global Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Castrate resistant prostate cancer (CRPC) is an advanced stage of prostate cancer that does not...
0 Комментарии 0 Поделились 951 Просмотры 0 предпросмотр
Спонсоры